United States · FDA National Drug Code directory
Phenazopyridine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50696-003_51a1c6ea-0152-879a-e063-6394a90af1df
- Product NDC
- 50696-003
- Form
- TABLET
- Composition / generic term
- Phenazopyridine Hydrochloride
- Labeler
- GPT Pharmaceuticals Private Limited
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260401
- Source listing expiry
- 20271231
Source-listed ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE — 99.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25000 TABLET in 1 DRUM (50696-003-01) · 50696-003-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →